REFERENCES
- Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ: Cancer Statistics 2007. CA Cancer J Clin. 2007;57:43–66.
- Baron-Epel O, Andreev H, Barchana M, Green MS: Smoking and incidence of lung cancer in Israel, 1981–1995 [in Hebrew]. Harefuah. 1999;136:522–527.
- Patel JD, Bach PB, Kris MG: Lung cancer in US women: a contemporary epidemic. JAMA. 2004;291:1763–1768.
- Boyle P, Maissonneuve P: Lung cancer and tobacco smoking. Lung Cancer. 1995;12:167–181.
- Alberg AJ, Samet JM: Epidemiology of lung cancer. Chest. 2003;123:21S–49S.
- Kreuzer M, Keienbrock L, Gerken M. Risk factors for lung cancer in young adults. Am J Epidemiol. 1998;147:1028–1037.
- Syrjanen KJ. HPV infections and lung cancer. J Clin Pathol. 2002;55:885–891.
- Grinstein S, Preciado MV, Gattuso P, Chabay PA, Warren WH, De Matteo E, : Demonstration of Epstein-Barr virus in carcinomas of various sites. Cancer Res. 2002;62:4876–4878.
- Galateau-Salle F, Bidet P, Iwatsubo Y, Gennetay E, Renier A, Letourneux M, : Detection of SV40-like DNA sequences in pleural mesothelioma, bronchopulmonary carcinoma and other pulmonary diseases. Dev Biol Stand. 1998;94:147–152.
- Brouchet L, Valmary S, Dahan M, Didier A, Galateau-Salle F, Brousset P, : Detection of oncogenic virus genomes and gene products in lung carcinoma. Br J Cancer. 2005;92:743–746.
- Giuliani L, Jaxmar T, Casadio C, Gariglio M, Manna A, D'Antonio D, : Detection of oncogenic viruses (SV40, BKV, JCV, HCMV, HPV) and p53 codon 72 polymorphism in lung carcinoma. Lung Cancer. 2007;57:273–281.
- Yousem SA, Finkelstein SD, Swalsky PA, Bakker A, Ohori NP: Absence of Jaagsiekte retrovirus DNA and RNA in bronchoalveolar and conventional human pulmonary adenocarcinoma by PCR and RT-PCR analysis. Hum Pathol. 2001;32:1039–1042.
- Benharroch D, Shemer-Avni Y, Myint YY, Levy A, Mejirovsky E, Suprun I, : Measles virus: evidence of an association with Hodgkin's disease. Br J Cancer. 2004;91:572–579.
- Rima BK, Paul Duprex W: Molecular mechanism of measles virus persistence. Virus Res. 2005;111:132–147.
- Chen M, Cortay JC, Logan IR, Sapountzi V, Robson CN, Gerlier D: Inhibition of ubiquitination and stabilization of human ubiquitin E3 ligase PIRH2 by measles virus phosphoprotein. J Virol. 2005;79:11824–11836.
- Duan W, Gao L, Druham LJ, Zhu W, Morrison C, Otterson GA, : Expression of Pirh2, a newly identified ubiquitin protein ligase in lung cancer. J Nat Cancer Inst. 2004;96:1718–1721.
- Varsano S, Rashkovsky L, Shapiro H, Ophir D, Mark-Bentankur T: Human lung cancer lines express cell membrane complement inhibitory proteins and are extremely resistant to complement-mediated lysis: a comparison with normal human respiratory epithelium in vitro, and an insight into mechanism(s) of resistance. Clin Exp Immunol. 1998;113:173–182.
- Schneider-Schaulies S, Kreth HW, Hofmann G, Billeter M, Ter Meulen V: Expression of measles virus RNA in peripheral blood mononuclear cells of patients with measles, SSPE, and autoimmune diseases. Virology. 1991;182:703–711.
- Matsuoka M: Human T-cell leukemia virus type I and adult T-cell leukemia. Oncogene. 2003;22:5131–5140.
- Ganem D: KSHV and Kaposi's sarcoma: the end of the beginning? Cell. 1997;91:157–160.
- zur Hausen H: Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst. 2000;92:690–698.
- Cheng YW, Chiou HL, Sheu GT, Hsieh LL, Chen JT, Chen CY, : The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res. 2001;61:2799–2803.
- Leng RP, Lin Y, Ma W, Wu H, Lemmers B, Chung S, : Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell. 2003;112:779–791.
- Haupt Y, Maya R, Kazaz A, Oren M: Mdm2 promotes the rapid degradation of p53. Nature. 1997;387:296–299.